Jiangsu University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02060084
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Affiliated Hospital of Jiangsu University | Kunshan First People's Hospital Affiliated to Jiangsu University | the Affiliated Lianyungang No. 2 People's Hospital of Jiangsu University | The Third Hospital of Zhenjiang Affiliated Jiangsu University | Traditional Chinese Medicine Hospital of KUNSHAN

Active Ingredients

Drugs in Phase 4 Trials (3)

octreotide (sandostatin) (1 trial)

probiotic (1 trial)

terlipressin (1 trial)

Drugs in Phase 2 Trials (3)

folic acid (1 trial)

moluodan (1 trial)

sanchi-tongshu (1 trial)

Drugs in Phase 1 Trials (2)

famotidine (pepcid) (1 trial)

hcd19.il15.car-inkt (1 trial)

Drugs in Other Trials (2)

dexmedetomidine (precedex) (1 trial)

midazolam (versed) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 4)

Feeding and Eating Disorders (Phase 4)

Feeding and Eating Disorders of Childhood (Phase 4)

Gastroesophageal Reflux (Phase 1)

Hemorrhage (Phase 4)

Precancerous Conditions (Phase 2)

Stomach Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 10